InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Struthers Richard Scott, Chairman & CEO. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Cumulatively, 32 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €4.3m. History available since 7 September 2021. The latest transaction was disclosed on 7 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Struthers Richard Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
4,422 shares@ US$22.610.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:1
6,542 shares@ US$15.290.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:2
4,995 shares@ US$20.020.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:3
3,969 shares@ US$25.190.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:0
13,196 shares@ US$37.116.7% of flowCommon StockSEC:0001628280-26-019488:0
62,000 shares0Common StockSEC:0001628280-26-011730:0
16,342 shares@ US$9.282.0% of flowCommon StockSEC:0001628280-25-058056:0
4,000 shares@ US$45.002.5% of flowCommon StockSEC:0001658247-25-000011:0
90,400 shares0Common StockSEC:0000950170-25-073605:0
81,270 shares@ US$1.912.3% of flowCommon StockSEC:0000950170-25-051170:0
16,463 shares@ US$34.178.3% of flowCommon StockSEC:0000950170-25-043401:0
89,000 shares0Common StockSEC:0000950170-25-025667:0
10,000 shares@ US$57.578.8% of flowCommon StockSEC:0000950170-24-133297:0
107,448 shares@ US$9.2814.9% of flowCommon StockSEC:0000950170-24-057926:0
350 shares0Common StockSEC:0000950170-24-046523:0
20,000 shares@ US$1.910.6% of flowCommon StockSEC:0000950170-24-045136:0
40,951 shares@ US$9.285.6% of flowCommon StockSEC:0000950170-24-042681:0
12,687 shares@ US$38.147.2% of flowCommon StockSEC:0001209191-24-005008:0
65,000 shares0Common StockSEC:0001209191-24-004608:0
60,000 shares0Common StockSEC:0001209191-24-003354:0
50,000 shares@ US$1.911.4% of flowCommon StockSEC:0001209191-23-055022:0
918 shares@ US$9.280.1% of flowCommon StockSEC:0001209191-23-054567:0
10,000 shares@ US$1.910.3% of flowCommon StockSEC:0001209191-23-046024:0
24,384 shares@ US$20.147.2% of flowCommon StockSEC:0001209191-23-042229:0
50,000 shares@ US$20.8115.3% of flowCommon StockSEC:0001209191-23-038851:0
25 of 32 declarations
About Struthers Richard Scott
Struthers Richard Scott is Président-Directeur Général and is associated with Crinetics Pharmaceuticals, Inc. on XNAS. He has 28 filings in total, and across the 28 sampled filings, the reported transactions run from 2021-09-09 to 2026-03-18, with EUR 0 of buys and EUR 4322255 of sells, and the modal transaction nature is Cession.
